Coronavirus Update: Following the money 25 January 2020

25 January 2020 — Off Guardian

Kit Knightly

Wuhan outbreak crowd image 2000x900

The Coronavirus is still the big-ticket news item, with confirmed cases now covering 11 countries. ELEVEN!

Most of the mainstream media are doing that, saying the number of countries rather than the number of people. I suppose because it carries the implication that, somehow, everyone in all those 11 countries is under some kind of imminent threat.

As of the time of writing, the real (or at least reportedly real) numbers stand at 1407 cases, 41 deaths. Which means the mortality rate is now actually below 3%.

For comparison’s sake – the death rate of the Ebola virus is 90%, Bubonic plague 40-60%, Smallpox was ~30%, and the 1918 Spanish flu between 10 and 20%. So we’re hardly dealing with a big-hitter here.

Even the hysterical-nothing burger that was SARS had a (reported) death rate approaching 10%. [For more on the links between SARS and the Wuhan outbreak see John Rappoport’s excellent work on subject].

For anyone doubting that, whatever the truth of the situation on the ground, this is being hyped to spread fear: The Guardian has a big red “LIVE BLOG” for the disease today. Counting up the death toll very slowly, and with what I would call a rather unseemly amount of enthusiasm.

China are building a whole new hospital, we’re being told. There are “bodies in the streets”, apparently:

The Daily Mail is reporting that an Australian research team is “racing against the clock” to engineer a vaccine. The researchers claim it will take them 6 months (a very fast turnaround for vaccine development, which usually takes years).

If the disease carries on its current trajectory, by the end of that six months roughly 7200 people will have been infected, around 250 of whom will have died.

In the same timeframe, about 15,000 people will have been injured in car accidents, and around 900 of them will have died…in the UK alone.

Based on that, you could argue the resources poured into the “race against time” would be better spent inventing stronger seat-belts or funding an anti-drink driving campaign.

After all, any good this hypothetical vaccine might do needs to be off-set against the potential dangers of injecting thousands – even millions – of people with a vaccine that will have had no long term safety studies whatsoever.

Of course, the Daily Mail doesn’t mention that.

Another thing The Daily Mail doesn’t mention is that the vaccine being developed by Queensland University is a cooperative project with Philadelphia-based Inovio Pharmaceuticals, who received a grant of $9 million to combat the Wuhan outbreak.

A second pharmaceutical firm, Co-Diagnostic Inc, has received a similar grant to develop a coronavirus “screening test”.

Inovio previously hit the headlines a few years ago, when they received a grant to create an anti-Zika vaccine (something they managed to do in less than six months).

The grants were distributed by the Coalition for Epidemic Preparedness Innovations (CEPI), an NGO that promotes global vaccination and is funded by the Bill and Melinda Gates Foundation (among others).

Inovio’s stock jumped 12% when it was announced they had been commissioned to manufacture the vaccine, whilst Co-Diagnostic’s stock almost doubled in value following the news :

[Co-Diagnostics Inc.’s stock] nearly doubled (up 80%) to a one-year high. Trading volume shot up to 36.1 million shares, compared with the full-day average of about 161,000 shares.

But that’s just the beginning. The CEO of Co-Diagnostics sees a much bigger windfall down the line (our emphasis):

Chief Executive Dwight Egan said in a statement that if the World Health Organization declares the illness a global health emergency, he believes Co-Diagnostics would be in position to “quickly assist” in providing its test to the affected countries.

Note the bolded.

Whatever else is going on, however real or otherwise this “outbreak” proves to be, “if the WHO declare a global health emergency”, some people are going to make a lot of money.

One thought on “Coronavirus Update: Following the money 25 January 2020

  1. crisscross767 says:

    The US has been working on the Corona virus for a few years –

    The Washington Post

    Germ Warfare
    By David Brown
    May 6, 2003

    “…………….On March 23, researchers at CDC found a coronavirus in the lung fluids of a dead SARS patient from Hong Kong. Coronaviruses are so named because they have spiky surfaces that make them resemble stars with coronas when viewed with an electron microscope. Soon after, the virus was grown into workable quantities in cell cultures……………..

    ……………..Which are better, live or killed vaccines? someone asks.

    Killed coronavirus vaccines, which are relatively safe, don’t work well, an expert answers. Vaccines made from live, weakened virus work better. But the one given to chickens to prevent bronchitis sometimes “reverts” to a dangerous form — a very undesirable outcome.

    For more than a half-hour, ideas spill forth. Both the uniformed people at the table and the voices on the phone pose questions and throw out theories like eager graduate students.

    Is the rare “super spreader” patient who infects a dozen or more people shedding the SARS virus in his or her digestive tract? Could the fact that some coronaviruses attack two organs explain why many SARS victims in the Amoy Gardens housing block in Hong Kong had intestinal complaints? Is there something in all of this that explains why so few children have come down with SARS?

    Read on –

    https://www.washingtonpost.com/archive/lifestyle/2003/05/06/germ-warfare/31709c4c-ef98-466b-9b0d-0ee76cdef3ca/

    https://patents.justia.com/

    Pirbright’s livestock coronavirus research
    Posted: 24 January, 2020

    ……….The Institute holds Patent no. 10130701 which covers the development of an attenuated (weakened) form of the coronavirus that could potentially be used as a vaccine to prevent respiratory diseases in birds and other animals. Many vaccines are made in this way, from flu to polio. We have not yet developed an IBV vaccine, but research is ongoing.

    The Institute is strategically funded by the Biotechnology and Biological Sciences Research Council, part of UK Research and Innovation (BBSRC UKRI) and also receives funding from many other organisations including the Bill & Melinda Gates Foundation. The patented work was not funded by the Bill & Melinda Gates Foundation. More information on The Livestock Antibody Hub which is funded by the Bill & Melinda Gates Foundation is available on our website…………

    https://www.pirbright.ac.uk/news/2020/01/pirbright%E2%80%99s-livestock-coronavirus-research-%E2%80%93-your-questions-answered

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.